NOVACLONE™ ANTI-CII (RH2) HUMAN MONOCLONAL IGM RH TYPING REAGENT - INVIMA Registration 87c6fc59f71d1d3aff4195004ba3233c
Access comprehensive regulatory information for NOVACLONE™ ANTI-CII (RH2) HUMAN MONOCLONAL IGM RH TYPING REAGENT (NOVACLONE™ ANTI-CII (RH2) HUMAN MONOCLONAL IGM RH TYPING REAGENT) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID 87c6fc59f71d1d3aff4195004ba3233c and manufactured by IMMUCOR INC.. The device was registered on June 28, 2026.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
ESTE REACTIVO DE AGRUPACIÓN DE SANGRE ESTÁN DESTINADOS PARA SU USO EN PRUEBAS DE PORTAOBJETOS, TUBOS Y MICROPLACAS Y PROPORCIONAN UNA PRUEBA ESPECÍFICA Y CUALITATIVA PARA LA DETECCIÓN DEL ANTÍGENO RH CORRESPONDIENTE EN LOS GLÓBULOS ROJOS HUMANOS.
THIS BLOOD POOLING REAGENT IS INTENDED FOR USE IN SLIDE, TUBE AND MICROPLATE TESTS AND PROVIDES A SPECIFIC AND QUALITATIVE TEST FOR THE DETECTION OF THE CORRESPONDING RH ANTIGEN IN HUMAN RED BLOOD CELLS.